Feature | Radiology Business | December 17, 2019 | Dave Fornell, Editor

Fujifilm Contemplating Purchase of Hitachi Medical Systems

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fufifilm capture a parger portion of international radiology market share. Photo by Dave Fornell.

The Hitachi Scenaria View CT scanner on display at the 2019 Radiological Society of North America (RSNA) meeting in December. This workhorse 64 or 128 slice CT system, and Hitchai's portfolio of MRI and ultrasound systems, is attracting the attention of Fujifilm, which does not have some of these technologies. Combined, the new new portfolio may help Fujifilm capture a larger portion of international radiology market share. Photo by Dave Fornell.

December 17, 2019 — It was disclosed today that Fujifilm may buy Hitachi's diagnostic imaging business in a deal that could be worth about $1.55 billion. This was according to the Nikkei Asian Review business daily, which first broke the story early on Dec. 17. 

The acquisition would be designed to expand Fujifilm's footprint in the radiology market to better complete internationally with the big three medical imaging companies — GE Healthcare, Siemens Healthineers and Philips Healthcare. Worldwide, the big three vendors control more than 60 percent of the medical imaging market.

Nikkei reported Fujifilm has been beefing up its medical equipment business, particularly endoscopy and X-ray imaging. It is turning its attention to the CT scanners, MRI devices and workhorse ultrasound severs, which Hitachi specializes in and Fujifilm is missing from its current radiology portfolio. 

Both company are also working on artificial intelligence (AI) applications for medical imaging. The merger would help expand Fujifilm's REiLE AI suite of AI products. Hitachi also offers software tools and AI to speed workflow and aid completion of medical imaging reports. 

The Board of Directors for both Fujifilm and Hitachi are supposed to hold meetings to vote on the proposed deal Wednesday, Dec. 18, according to Nikkei. 

Reuters also reported Hitachi has been reorganizing its business, selling non-core assets, while buying foreign businesses to help expand its digital businesses.

Toshiba followed a similar path in recent years, selling off its medical imaging division to Canon. All of the Japanese medical imaging companies have struggled to gain a larger portion of international market share outside of Japan. Consolidation of these companies in recent years has been seen as a way to increase market share and help build wider medical imaging portfolios. 

 

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 07, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Robert L.
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
Jeannie Danker, M.D. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Jeannie Danker, M.D. Photo courtesy of The Ohio State University Wexner Medical Center

News | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane
April 3, 2020 — The radiology world has lost a dedicated leader due to...
An estimated 44 million people worldwide are currently living with Alzheimer’s disease, the most common form of dementia. About 5.8 million people in the United States live with the disease, where it is the sixth leading cause of death overall. While there is not yet a cure for Alzheimer’s, researchers are working to find treatment options to delay its onset and prevent it from developing.

Image courtesy of Insightec

Feature | Ultrasound Imaging | April 02, 2020 | By Katie Caron
An estimated 44 million people worldwide are currently living with...